We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GNLN:NASDAQGreenlane Holdings, Inc. Analysis

Data as of 2026-04-06 - not real-time

$2.80

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Greenlane Holdings is trading at $2.80, well below its 20‑day SMA of $5.05 and 50‑day SMA of $6.97, signaling a strong bearish price bias. The 14‑day RSI of 31 and a bearish MACD histogram reinforce the downside momentum, while volatility is extreme at over 200% in the past 30 days. Valuation metrics such as a price‑to‑book of 0.35 and price‑to‑sales of 5.13 suggest the stock is cheap relative to its assets, but fundamental health is poor with negative margins, a -99.86% max drawdown, and zero earnings per share. Recent corporate communications highlight a shift toward a Berachain‑focused Digital Asset Treasury, with roughly 70 million BERA units held and 50 million deployed, indicating a potential new revenue stream. However, the company remains loss‑making, with operating cash flow and free cash flow both negative, and carries modest debt. The sector—cannabis‑related consumer defensive—faces high regulatory scrutiny, and the stock’s beta near 1 implies market‑level price swings. Overall, the combination of technical weakness, distressed fundamentals, and regulatory exposure creates a high‑risk profile despite an ostensibly low valuation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below both 20‑day and 50‑day SMAs
  • Bearish MACD crossover and negative histogram
  • RSI in oversold territory indicating further downside potential

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued negative earnings and cash flow
  • Potential upside from the digital asset treasury initiative
  • Low price‑to‑book ratio providing a relative valuation floor

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • High regulatory uncertainty in the cannabis accessories market
  • Persistent lack of profitability and negative margins
  • Limited dividend prospects and modest debt levels

Key Metrics & Analysis

Financial Health

Revenue Growth-18.00%
P/E Ratio-0.5
ROE-231.28%
ROA-62.89%
Debt/Equity0.24
P/B Ratio0.3
Op. Cash Flow$-16260000
Free Cash Flow$-904250

Technical Analysis

TrendBearish
RSI31.2
Support$2.09
Resistance$7.11
MA 20$5.05
MA 50$6.97
MA 200$21.94
MACDBearish
VolumeStable
Fear & Greed Index78.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.98
Volatility200.30%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.